For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Renovis, Inc.

USPTO Granted Patents = 17

% Expired Patents = 88.2

EPO Patents = 2

Forward Citations = 68

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Michael G Kelly (11 out of 72 patents)

John Kincaid (10 out of 19 patents)

Satyanarayana Janagani (6 out of 9 patents)

4. Guoxian Wu (4 out of 44 patents)

5. Allan L Wilcox (4 out of 34 patents)

6. Ravindra B Upasani (4 out of 9 patents)

7. Carl J Kaub (4 out of 11 patents)

8. Yunfeng Fang (4 out of 12 patents)

9. Zhi-Liang Wei (3 out of 10 patents)

10. L David Waterbury (3 out of 5 patents)

11. M Amin Khan (2 out of 46 patents)

12. Zhan Wang (2 out of 21 patents)

13. Matthew Duncton (2 out of 42 patents)

14. Paul L Wood (2 out of 7 patents)

15. Yeyu Cao (2 out of 7 patents)

17 patents: Sort by Forward Citations

1. 8093265 - Bicycloheteroaryl compounds as P2X7 modulators and uses thereof (2012-01-10),

2. 7816371 - [object Object] (2010-10-19),

3. 7745451 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions (2010-06-29),

4. 7576099 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2009-08-18),

5. 7432281 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2008-10-07),

6. 7414131 - Bicycloheteroarylamine compounds as ion channel ligands and uses thereof (2008-08-19),

7. 7402596 - Bicycloheteroaryl compounds as P2X7 modulators and uses thereof (2008-07-22),

8. 7338950 - Amide compounds as ion channel ligands and uses thereof (2008-03-04),

9. 7312330 - Bicycloheteroarylamine compounds as ion channel ligands and uses thereof (2007-12-25),

10. 7312233 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2007-12-25),

11. 7297700 - [object Object] (2007-11-20),

12. 7115666 - Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain (2006-10-03),

13. 7005546 - Acetamidobenzamide compounds for neurodegenerative disorders (2006-02-28),

14. 6998419 - 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same (2006-02-14),

15. 6835754 - Use of aryl nitrone compounds in methods for treating neuropathic pain (2004-12-28),

Renovis, Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for neurological disorders. The organization specializes in the research and development of novel drug candidates aimed at addressing unmet medical needs in the field of neurology. By leveraging advanced scientific methodologies and a deep understanding of neurobiology, Renovis strives to create impactful solutions that enhance patient outcomes and improve quality of life for individuals affected by these conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#78 in South San Francisco, CA

#4,509 in California

#18,881 in US

#35,887 in the World

South San Francisco, CA, United States of America

Renovis, Inc.

Forward Citations = 68

25 inventors:

Michael G Kelly (11 out of 72 patents)

John Kincaid (10 out of 19 patents)

Satyanarayana Janagani (6 out of 9 patents)

4. Guoxian Wu (4 out of 44 patents)

5. Allan L Wilcox (4 out of 34 patents)

Please report any incorrect information to [email protected]

Loading…